{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:49Z","timestamp":1786988149207,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tarbiat Modares University of Medical Sciences, Tehran, Iran"},{"name":"Iranian Council for Stem Cell Sciences and Technologies","award":["170"],"award-info":[{"award-number":["170"]}]},{"DOI":"10.13039\/501100001825","name":"Danish Agency for Science, Technology and Innovation","doi-asserted-by":"publisher","award":["12-126894"],"award-info":[{"award-number":["12-126894"]}],"id":[{"id":"10.13039\/501100001825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejps.2018.06.019","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T15:27:52Z","timestamp":1529422072000},"page":"42-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept"],"prefix":"10.1016","volume":"122","author":[{"given":"Shahryar","family":"Khoshtinat Nikkhoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-8366","authenticated-orcid":false,"given":"Fatemeh","family":"Rahbarizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davoud","family":"Ahmadvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Moein","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.06.019_bb0005","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1038\/sj.onc.1204305","article-title":"Expression of a truncated 100\u202fkDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation","volume":"20","author":"Aigner","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2018.06.019_bb0010","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1128\/JVI.03178-13","article-title":"Single domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge","volume":"88","author":"Cardoso","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1535-7163.MCT-06-0159","article-title":"Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs","volume":"6","author":"Chiu","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2018.06.019_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.maturitas.2010.10.012","article-title":"New therapeutic approaches in breast cancer","volume":"68","author":"Davies","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/j.ejps.2018.06.019_bb0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.tibtech.2014.03.001","article-title":"Nanobody-based products as research and diagnostic tools","volume":"32","author":"De Meyer","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1517\/14712598.2013.800478","article-title":"Camelid single-domain antibody-fragment engineering for (pre) clinical in vivo molecular imaging applications: adjusting the bullet to its target","volume":"13","author":"De Vos","year":"2013","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ejps.2018.06.019_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12934-014-0140-1","article-title":"Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies","volume":"13","author":"Djender","year":"2014","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ejps.2018.06.019_bb0040","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-15-1518","article-title":"Dual HER2 targeting with trastuzumab and liposomal-encapsulated doxorubicin (MM-302) demonstrates synergistic antitumor activity in breast and gastric cancer","volume":"76","author":"Espelin","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2018.06.019_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ab.2013.03.020","article-title":"VHH (nanobody) directed against human glycophorin a: a tool for autologous red cell agglutination assays","volume":"438","author":"Habib","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2018.06.019_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.06.019_bb0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0005-2736(95)00138-S","article-title":"Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures","volume":"1239","author":"Hansen","year":"1995","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.ejps.2018.06.019_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-4827(02)00099-X","article-title":"The ErbB receptors and their role in cancer progression","volume":"284","author":"Holbro","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2018.06.019_bb0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0070","doi-asserted-by":"crossref","first-page":"32682","DOI":"10.1074\/jbc.M114.580845","article-title":"Interactions between metal-binding domains modulate intracellular targeting of Cu(I)-ATPase ATP7B, as revealed by nanobody binding","volume":"289","author":"Huang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2018.06.019_bb0075","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.yexcr.2012.03.004","article-title":"Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells","volume":"318","author":"Jamnani","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2018.06.019_bb0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbagen.2013.09.029","article-title":"T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy","volume":"1840","author":"Jamnani","year":"2014","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejps.2018.06.019_bb0085","doi-asserted-by":"crossref","first-page":"20618","DOI":"10.1074\/jbc.M111359200","article-title":"Herstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signalling pathways resulting in growth arrest","volume":"277","author":"Justman","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2018.06.019_bb0090","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2018.06.019_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1593\/neo.08314","article-title":"A splice variant of HER2 corresponding to herstatin is expressed in the noncancerous breast and in breast carcinoma","volume":"10","author":"Kolesta","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejps.2018.06.019_bb0100","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/MCB.21.12.3995-4004.2001","article-title":"HER2 (neu) signalling increases the rate of hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) synthesis: novel mechanism of HIF-1-mediated vascular endothelial growth factor expression","volume":"21","author":"Laughner","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0105","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1200\/JCO.2008.17.3989","article-title":"Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients","volume":"27","author":"Leary","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2859-11-56","article-title":"Shuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulphide bonded proteins in its cytoplasm","volume":"11","author":"Lobstein","year":"2012","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ejps.2018.06.019_bb0115","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1158\/1535-7163.MCT-09-0295","article-title":"An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance","volume":"8","author":"Mitra","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejps.2018.06.019_bb0120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.nano.2014.04.011","article-title":"Just so stories: the random act of anti-cancer nanomedicine performance","volume":"10","author":"Moghimi","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2018.06.019_bb0125","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1021\/nn2038252","article-title":"Reshaping the future of nanopharmaceuticals: ad iudicium","volume":"5","author":"Moghimi","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejps.2018.06.019_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.tips.2014.03.003","article-title":"GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics","volume":"35","author":"Muji-Delic","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejps.2018.06.019_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbamcr.2004.02.012","article-title":"Catlysis of disulphide bond formation and isomerization in the Escherichia coli periplasm","volume":"1694","author":"Nakamoto","year":"2004","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"1","key":"10.1016\/j.ejps.2018.06.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-10-1","article-title":"Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulphide bond containing proteins expressed in the cytoplasm of E. coli","volume":"10","author":"Nguyen","year":"2011","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ejps.2018.06.019_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.15171\/ijb.1429","article-title":"Synergistic effect of expressed miR-128 and Puma protein on targeted induction of tumor cell apoptosis","volume":"14","author":"Nikkhoi","year":"2016","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pep.2016.09.012","article-title":"Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: new biology and novel targeting systems","volume":"129","author":"Nikkhoi","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejps.2018.06.019_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molimm.2018.01.010","article-title":"Liposomal nanoparticle armed with bivalent bispecific single-domain antibodies, novel weapon in HER2 positive cancerous cell lines targeting","volume":"96","author":"Nikkhoi","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2013.08.298","article-title":"Targeting tumors with nanobodies for cancer imaging and therapy","volume":"172","author":"Oliveira","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.06.019_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biomaterials.2016.07.027","article-title":"ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals","volume":"112","author":"Ordonez-Gutierrez","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.06.019_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3835(97)00326-1","article-title":"Anti-HER2 immunoliposomes for targeted therapy of human tumors","volume":"118","author":"Park","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2018.06.019_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0168-3659(01)00315-7","article-title":"Tumor targeting using anti-her2 immunoliposomes","volume":"74","author":"Park","year":"2001","journal-title":"J. Control. Release"},{"issue":"Suppl. 13","key":"10.1016\/j.ejps.2018.06.019_bb0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.seminoncol.2004.08.009","article-title":"Future directions of liposome- and immunoliposomes-based cancer therapeutics","volume":"31","author":"Park","year":"2004","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrd2241","article-title":"Development trends for monoclonal antibody cancer therapeutics","volume":"6","author":"Reichert","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2018.06.019_bb0195","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/jam.13441","article-title":"Co-expression of sulphydryl oxidase and protein disulphide isomerase in Escherichia coli allows for production of soluble CRM197","volume":"122","author":"Roth","year":"2017","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Salmon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ejps.2018.06.019_bb0205","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/312513a0","article-title":"The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen","volume":"312","author":"Schechter","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.06.019_bb0210","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1128\/MCB.13.4.2247","article-title":"A truncated intracellular HER2\/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells","volume":"13","author":"Scott","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0215","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.1241145","article-title":"Antibody therapeutics in cancer","volume":"341","author":"Sliwkowski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejps.2018.06.019_bb0220","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejpb.2016.05.023","article-title":"Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid","volume":"105","author":"Sriraman","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.06.019_bb0225","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2018.06.019_bb0230","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/protein\/gzv032","article-title":"An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation","volume":"28","author":"Ta","year":"2015","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ejps.2018.06.019_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pep.2011.03.005","article-title":"Improved quantitative and qualitative production of single-domain intrabodies mediated by the co-expression of Erv1p sulfhydryl oxidase","volume":"79","author":"Veggiani","year":"2011","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejps.2018.06.019_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.11.021","article-title":"An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal products Doxil\u00ae, Caelyx\u00ae, DOXOrubicin, and SinaDoxosome","volume":"221","author":"Wibroe","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.06.019_bb0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejps.2018.06.019_bb0250","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3109\/10717544.2015.1040527","article-title":"Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma","volume":"23","author":"Yuan","year":"2016","journal-title":"Drug Deliv."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718302756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T18:43:03Z","timestamp":1604428983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718302756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":49,"alternative-id":["S0928098718302756"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.019","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}